Skip to main content
$0.62 -$0.01 (-1.4%)

02:09 PM EST on 12/02/20

Novabay Pharmaceuticals Inc Com (NYSEMKT:NBY)

CAPS Rating: No stars

Current Price $0.62 Mkt Cap $26.1M
Open $0.62 P/E Ratio 0.00
Prev. Close $0.62 Div. (Yield) $0.00 (0.0%)
Daily Range $0.60 - $0.62 Volume 235,135
52-Wk Range $0.24 - $1.94 Avg. Daily Vol. 1,041,881

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

15 Outperform
6 Underperform
 

All-Star Players

3 Outperform
3 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSEMKT:NBY Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (97.59)
Submitted February 15, 2014

In retrospect, passing over NovaBay in November when it dropped to 0.9 in the wake of the failure of the impetigo trial was a clear missed opportunity. Even though I believe the company and its particular twitch on bleach dilution are hopeless for… More

allstar31 (99.94)
Submitted September 12, 2014

Uses known stock pump and dump promoter Redchip.com. Garbage.

Recent Community Commentary

Read the most recent pitches from players about NBY.

Recs

1
Member Avatar allstar31 (99.94) Submitted: 9/11/2014 10:15:27 PM : Underperform Start Price: $22.50 NYSE MKT:NBY Score: +180.04

Uses known stock pump and dump promoter Redchip.com. Garbage.

Recs

0
Member Avatar timc1981 (68.51) Submitted: 2/12/2014 9:58:01 AM : Outperform Start Price: $30.00 NYSE MKT:NBY Score: -198.32

I think NBY will have tremendous growth in the next 2 years. They've got one product on the market (Neutrophase), and it's picking up steam in the US and China. They've also got clinical trials that have yielded positive results, and should have more trial results soon. They've also got a little influx of cash from their partnership with China Pioneer Pharma Holdings Limited, which will help their solvency prospects in the near term. I'm as encouraged about the Neutrophase prospects as I am about their trials for a treatment to the adenovirus (BAYNovation).

Recs

0
Member Avatar fooly4u (< 20) Submitted: 1/20/2012 12:04:32 AM : Outperform Start Price: $39.75 NYSE MKT:NBY Score: -277.13

A Winner Just Wait.

Leaderboard

Find the members with the highest scoring picks in NBY.

Score Leader

marcjones281

marcjones281 (< 20) Score: +277.20

The Score Leader is the player with the highest score across all their picks in NBY.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
marcjones281 < 20 1/19/2012 Underperform 5Y $42.25 -98.54% +178.66% +277.20 0 Comment
allstar31 99.94 9/12/2014 Underperform 5Y $22.50 -97.26% +82.78% +180.04 1 Comment
jasonrivera 32.03 1/13/2016 Underperform 5Y $2.28 -73.00% +93.33% +166.32 0 Comment
warrenout 32.62 1/4/2016 Underperform 5Y $1.95 -68.43% +82.42% +150.85 0 Comment
DontFeedTheBears 96.05 6/28/2019 Underperform 3Y $1.68 -63.35% +25.04% +88.39 0 Comment
jaltman 98.59 6/24/2020 Underperform 5Y $0.94 -34.50% +18.09% +52.59 0 Comment
drugtrader 91.62 6/25/2020 Outperform 5Y $1.07 -42.46% +19.97% -62.43 0 Comment
akakoolestkat < 20 3/22/2016 Outperform 3Y $2.35 -73.80% +78.24% -152.04 0 Comment
rajalonghorn 45.01 2/25/2014 Outperform 1Y $32.50 -98.11% +97.67% -195.77 0 Comment
peregrine 94.32 4/7/2014 Outperform 5Y $27.75 -97.78% +98.19% -195.97 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for NBY.